The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

A research team at Mount Sinai have developed a risk score they found accurate in predicting Crohn’s disease in patients ...

“BRI has been found to be superior in estimating risk for clinical endpoints including cardiometabolic disease, kidney ...

U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed ...

Talzenna is currently approved in combination with Xtandi (enzalutamide) for individuals with castration-resistant prostate ...

Healthcare professionals (HCPs) may need a reminder that their LGBTIQ+ patients are more than just their cancer diagnoses. | ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Pfizer Inc. failed to convince advisers to the US Food and Drug Administration to support a dramatic expansion in the use of ...

To increase women representation in the pharmaceutical industry, Pfizer Global Supply’s manufacturing unit in Visakhapatnam ...

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

My monthly update and commentary on the top dividend stock picks from the Barron's Better Bets list, May 2025 edition. Read ...